- Home
- » Tags
- » Baxter International
Top View
- 2014 Annual Report
- Participant List
- Alexion Announces Additions to Executive Leadership Team
- Baxter International Inc. (Exact Name of Registrant As Specified in Its Charter)
- Baxter International Inc. Delivered Successfully on a Wide Range of Strategic Objectives in 2014
- The State of Utah V. APOTEX CORPORATION
- For Immediate Release
- General Information: Terms of Sale / Return Goods Policy
- The 3.8 Initiative
- Vaccine IP Enforcement Takes Stage in Global Immunization Fight
- March 8, 2021
- Productive Innovation Index 2015 White Paper
- 2019 PQMD Global Health Policy Forum
- Major Medical Products and Services Companies Establish Global Healthcare Exchange
- Gilead, Celgene, Biogen Head List of Most Productive Biopharmas
- Pfizer Johnson & Johnson
- Ligand's Technologies Support and Enable Potential Coronavirus Treatments
- ALEXION PHARMACEUTICALS, INC. (Exact Name of Registrant As Specified in Its Charter)
- Baxter International Annual Report 2021
- Amgen 2011 Annual Report and Financial Summary
- Putnam VT Large Cap Value Fund Q1 Portfolio Holdings
- Biogen CEO Pick Vounatsos Suggests a Return to Commercial Focus
- Portfolio of Investments
- BAXTER INTERNATIONAL INC. (Exact Name of Registrant As Specified in Its Charter) ______Delaware 36-0781620 (State Or Other Jurisdiction of (I.R.S
- Baxter International Inc. Ellen [email protected]
- Corporate Headquarters Baxter International Inc. One Baxter
- In the United States District Court for the District of New Jersey
- Baxter International Inc. (Exact Name of Registrant As Specified in Its Charter) Delaware 36-0781620 (State Or Other Jurisdiction of (I.R.S
- Progress. Opportunity. Growth. Hospira Is the World’S Leading Provider of Injectable Drugs and Infusion Technologies
- Philanthropic Topics
- Top 50 Companies Ranked by Healthcare Revenue
- Drug Companies and Their Role in Aiding Executions
- Appendix a 2017 Financial Report Financial Review Pfizer Inc
- Full Text Decision US
- Industry Partnerships on COVID-19 Vaccines, Therapeutics and Diagnostics
- Federal Register/Vol. 68, No. 5/Wednesday, January 8, 2003
- Updated April 15, 2021 Industry Partnerships on COVID-19
- Agmen Inc. 2009 Annual Report
- Baxter International Inc. I Exchange Offer
- Healthcare FOCUS
- Baxter International Inc. (Exact Name of Registrant As Specified in Its Charter) ______Delaware 36-0781620 (State Or Other Jurisdiction of (I.R.S
- Digital Health Monitor – Pharmaceuticals
- The Procter & Gamble Company Exchange Offer
- Ligand Announces Its Captisol Business Is Positioned for Major Growth and Forecasts 2021 Captisol Material Sales of $200 Million
- Merck & Co., Inc
- Biopharmaceutical Capabilities Pharmaceutical Grade Water and Pure Steam at Maximum Uptime